| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| review article | Q7318358 |
| P2093 | author name string | van Hillegersberg R | |
| Ruurda JP | |||
| Visser E | |||
| Brosens LA | |||
| Franken IA | |||
| P2860 | cites work | RNA-Seq: a revolutionary tool for transcriptomics | Q24596169 |
| Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries | Q26799758 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis | Q28087347 | ||
| Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer | Q29619394 | ||
| RNA sequencing: advances, challenges and opportunities | Q29619605 | ||
| Genome-wide gene expression profile analysis of esophageal squamous cell carcinomas | Q33242931 | ||
| Gene expression profiling of lymph node metastasis by oligomicroarray analysis using laser microdissection in esophageal squamous cell carcinoma. | Q33262850 | ||
| Capecitabine and oxaliplatin for advanced esophagogastric cancer. | Q33313072 | ||
| Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome | Q33770008 | ||
| Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma | Q33866777 | ||
| Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis. | Q34090537 | ||
| Genome-wide gene expression profile analyses identify CTTN as a potential prognostic marker in esophageal cancer | Q35097632 | ||
| Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review | Q36238943 | ||
| The consensus molecular subtypes of colorectal cancer | Q36258187 | ||
| Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent | Q36391839 | ||
| Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. | Q36487139 | ||
| Staging of oesophageal cancer | Q36963735 | ||
| Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues. | Q37061599 | ||
| Assessing bias in studies of prognostic factors | Q38082694 | ||
| Injurious effects of radiation on the esophagus. | Q38140588 | ||
| Differential gene expression profiling of esophageal adenocarcinoma | Q38422200 | ||
| Gene expression profiling of esophageal cancer: comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma | Q38516998 | ||
| Prediction of lymph node metastasis with use of artificial neural networks based on gene expression profiles in esophageal squamous cell carcinoma. | Q40467920 | ||
| Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. | Q40645806 | ||
| Prediction of the response to chemotherapy in advanced esophageal cancer by gene expression profiling of biopsy samples | Q42874138 | ||
| A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia | Q42973684 | ||
| Microarray-based response prediction in esophageal adenocarcinoma | Q43211439 | ||
| Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial | Q44017893 | ||
| Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer | Q44541885 | ||
| Gene expression profiles in esophageal adenocarcinoma predict survival after resection | Q44712922 | ||
| Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy | Q45210122 | ||
| Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer. | Q45965183 | ||
| Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas | Q46325468 | ||
| Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagus | Q46339907 | ||
| The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. | Q46373510 | ||
| Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer | Q46578200 | ||
| Correlation of overall survival with gene expression profiles in a prospective study of resectable esophageal cancer. | Q51565125 | ||
| Expression profile of metastasis-associated genes in esophageal squamous cell carcinoma. | Q51584793 | ||
| Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer. | Q51996819 | ||
| Esophageal squamous cell carcinomas with distinct invasive depth show different gene expression profiles associated with lymph node metastasis. | Q52021461 | ||
| An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. | Q53572323 | ||
| Genome-wide screening and co-expression network analysis identify recurrence-specific biomarkers of esophageal squamous cell carcinoma. | Q54196068 | ||
| Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer | Q56601042 | ||
| Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer | Q57259796 | ||
| Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations | Q72458494 | ||
| Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma | Q73865114 | ||
| Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation | Q81417060 | ||
| Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation | Q81606607 | ||
| Esophageal carcinoma | Q86401144 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | transcriptome | Q252857 |
| adenocarcinoma | Q356033 | ||
| systematic review | Q1504425 | ||
| esophageal cancer | Q372701 | ||
| squamous cell carcinoma | Q681817 | ||
| esophageal neoplasm | Q56014520 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P577 | publication date | 2016-11-12 | |
| 2017-01-17 | |||
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Prognostic gene expression profiling in esophageal cancer: a systematic review |
| Q64058357 | A world map of esophagus cancer research: a critical accounting |
| Q88125421 | Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug |
| Q36346554 | Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis |
| Q59793482 | Cytoskeleton-associated protein 4 is a novel serodiagnostic marker for esophageal squamous-cell carcinoma |
| Q42131289 | Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution |
| Q47161221 | Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling. |
| Q49196010 | Network analysis of common genes related to esophageal, gastric, and colon cancers |
| Q47098880 | Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma |
| Q92511968 | Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma |
| Q92024244 | Reduced miR-203 predicts metastasis and poor survival in esophageal carcinoma |
| Q98224335 | Targeting deubiquitinating enzyme USP26 by microRNA-203 regulates Snail1's pro-metastatic functions in esophageal cancer |
| Q60960098 | The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy |
| Q89471675 | The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis |
Search more.